| |
| |
|
| Insider
Information: |
Patou Gary |
| Relationship: |
|
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
37,714 |
|
|
Indirect Shares
|
5,604 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$20,842 |
|
|
| Total
Shares |
43,318 |
|
|
| Total
Value |
$20,842 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Oscient Pharmaceuticals Corp |
OSCIQ |
Director |
2008-06-12 |
14,141 |
2004-11-02 |
0 |
Premium* |
|
|
Pacira Pharmaceuticals, Inc. |
PCRX |
Chief Medical Officer |
2014-08-07 |
0 |
2014-08-07 |
702 |
Premium* |
|
|
Xenon Pharmaceuticals Inc. |
XENE |
|
2023-12-13 |
23,573 |
2023-12-14 |
4,902 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
150 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-11-29 |
4 |
OE |
$0.07 |
$533 |
D/D |
7,614 |
405,470 |
|
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Chief Medical Officer |
• – – |
2013-04-01 |
4 |
OE |
$1.61 |
$48,300 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Chief Medical Officer |
• – – |
2013-04-12 |
4 |
OE |
$1.61 |
$16,100 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Chief Medical Officer |
• – – |
2013-07-01 |
4 |
OE |
$1.61 |
$48,300 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Chief Medical Officer |
• – – |
2013-07-02 |
4 |
OE |
$1.61 |
$16,100 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Chief Medical Officer |
• – – |
2013-10-01 |
4 |
OE |
$1.61 |
$32,200 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Chief Medical Officer |
• – – |
2014-05-09 |
4 |
OE |
$1.61 |
$58,724 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Chief Medical Officer |
• – – |
2014-05-12 |
4 |
OE |
$5.49 |
$54,900 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Chief Medical Officer |
• – – |
2014-07-14 |
4 |
OE |
$1.61 |
$194,007 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Chief Medical Officer |
• – – |
2014-08-07 |
4 |
OE |
$1.61 |
$203,258 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2015-01-07 |
4 |
OE |
$4.98 |
$17,415 |
D/D |
3,497 |
3,497 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2015-11-04 |
4 |
OE |
$5.22 |
$18,254 |
D/D |
3,497 |
6,041 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2016-12-06 |
4 |
OE |
$3.21 |
$39,627 |
D/D |
12,345 |
16,431 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2018-06-14 |
4 |
OE |
$3.70 |
$30,451 |
D/D |
8,230 |
20,258 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2018-12-14 |
4 |
OE |
$3.07 |
$6,315 |
D/D |
2,057 |
19,459 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2019-12-04 |
4 |
OE |
$3.56 |
$7,323 |
D/D |
2,057 |
21,516 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2020-10-28 |
4 |
OE |
$3.76 |
$7,734 |
D/D |
2,057 |
23,573 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2021-12-08 |
4 |
OE |
$3.67 |
$7,549 |
D/D |
2,057 |
25,630 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2022-11-25 |
4 |
OE |
$2.68 |
$5,513 |
D/D |
2,057 |
25,630 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
|
– • – |
2023-12-13 |
4 |
OE |
$9.00 |
$137,487 |
D/D |
14,402 |
28,717 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2022-11-23 |
4 |
S |
$34.33 |
$70,610 |
D/D |
(2,057) |
23,573 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2022-11-25 |
4 |
S |
$34.79 |
$67,390 |
D/D |
(1,937) |
23,573 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
|
– • – |
2023-12-13 |
4 |
S |
$38.94 |
$447,085 |
D/D |
(11,380) |
23,573 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
|
– • – |
2023-12-13 |
4 |
S |
$41.05 |
$311,898 |
I/I |
(7,598) |
4,902 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
|
– • – |
2023-12-14 |
4/A |
S |
$41.05 |
$311,898 |
I/I |
(7,598) |
4,902 |
0 |
- |
|
150 Records found
|
|
Page 6 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
